EN-1078D

Endometrial carcinoma cell line originiating from simple epithelial cells. Positive for both estrogen receptor isoforms and progesterone receptor B, presents mutations in PTEN and K-Ras genes, one tumor suppressor and one oncogene frequently mutated in endometrial cancers. Cell line expresses high levels of MMP-2 , no MMP-9 and weak expression of TIMP-2. Cells have weak levels of phosphorylated Akt adn sow sensitivity to drugs commonly used in chemotherapy. Very aggressive cell line with high invasiveness in vitro Useful for studying mechanisms involved in the invasion of endometrial cancer cells and their regulation by sex steroids.

Contributors

Inventor Institute
Anne-Marie Mes-Masson and Diane Provencher Centre Hospitalier de L’université de Montréal
SKU: 161896
Product description: Endometrial carcinoma cell line originiating from simple epithelial cells. Positive for both estrogen receptor isoforms and progesterone receptor B, presents mutations in PTEN and K-Ras genes, one tumor suppressor and one oncogene frequently mutated in endometrial cancers. Cell line expresses high levels of MMP-2 , no MMP-9 and weak expression of TIMP-2. Cells have weak levels of phosphorylated Akt adn sow sensitivity to drugs commonly used in chemotherapy. Very aggressive cell line with high invasiveness in vitro Useful for studying mechanisms involved in the invasion of endometrial cancer cells and their regulation by sex steroids.
CRISPR: No
Production details: Tumor was minced with scisors into OSE without FBS. Enzymatic dissociation was done and the cellular fraction was diluted 1:5 in OSE media with 10% FBS in 37C in 5%CO2 for 24-28 hours. After cells were able to adhere, they were washed with PBS and passaged with OSE + 10% FBS until cell line was established. Afterwards, cells were grown and maintained in DMEM-F12 with HEPES (4-(4-hydroxyethyl)-1-piperazineethanesulfonic acid) adn teh medium was supplemented with 10&v/v bovine growth serum (BGS) and 50ug/ml gentamycin.
Cellosaurus ID: CVCL_A423
Disease: Cancer
Cat. #: 161896
Cancer types: Ovarian cancer
Research Fields: Cancer
Organism: Human
Tissue: Ovary
Morphology: Small polygonal cells organized in pavement-like arrangement
Growth properties: Mixed
Primary citation: Dery et al. 2007. Reproductive Biology and Endocrinology. 25,5:(38). PMID 17894888
Format: Frozen
Storage conditions: Liquid Nitrogen
Shipping conditions: Dry Ice
Growth medium: Grown and maintained in DMEM-F12 with HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) supplemented with 10% v/v bovine growth serum (BGS) and 50 ug/ml gentamycin. For experimentation without steroid hormones, cell line cultured 2 weeks minimum in phenol-free DMEM-F12 supplemented with 10% v/v dextran-charcol stripped FBS and 50ug/ml gentamycin.
Temperature: 37° C
Atmosphere: 5% CO2
Biosafety level: 1
References:

Fabi, et al. 2021. Mol Oncol. 15(8):2106-2119. PMID: 33338300

Aslan, et al. 2018. BMC Cancer. 9,18(1):168. PMID: 29426295

Coyne, et al. 2013. J Clin Exp Oncol. 2(2):1000109. PMID: 26251840

Dery et al. 2007. Reproductive Biology and Endocrinology. 25,5:(38). PMID 17894888

Related Tools for Cell lines

Cat. # Tool Name
151484 2fTGH Cell Line Key Info View Tool
151576 MEF RAF1 KO Cell Line Key Info View Tool
151425 TR146 Cell Line Key Info View Tool
151488 B6.1.1 Mouse ES Cell Line Key Info View Tool
151503 1-7 CE1 Cell Line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.